Page last updated: 2024-11-02

pargyline and Pituitary Neoplasms

pargyline has been researched along with Pituitary Neoplasms in 1 studies

Pargyline: A monoamine oxidase inhibitor with antihypertensive properties.

Pituitary Neoplasms: Neoplasms which arise from or metastasize to the PITUITARY GLAND. The majority of pituitary neoplasms are adenomas, which are divided into non-secreting and secreting forms. Hormone producing forms are further classified by the type of hormone they secrete. Pituitary adenomas may also be characterized by their staining properties (see ADENOMA, BASOPHIL; ADENOMA, ACIDOPHIL; and ADENOMA, CHROMOPHOBE). Pituitary tumors may compress adjacent structures, including the HYPOTHALAMUS, several CRANIAL NERVES, and the OPTIC CHIASM. Chiasmal compression may result in bitemporal HEMIANOPSIA.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
MacLeod, RM1
Fontham, EH1
Lehmeyer, JE1

Other Studies

1 other study available for pargyline and Pituitary Neoplasms

ArticleYear
Prolactin and growth hormone production as influenced by catecholamines and agents that affect brain catecholamines.
    Neuroendocrinology, 1970, Volume: 6, Issue:5

    Topics: Animals; Catecholamines; Depression, Chemical; Dopamine; Female; Growth Hormone; Guanethidine; In Vi

1970